Related references
Note: Only part of the references are listed.Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells
Haranatha R. Potteti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway
Karthik Reddy Kami Reddy et al.
ACS COMBINATORIAL SCIENCE (2019)
Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells
Sujin Lee et al.
REDOX BIOLOGY (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Chemical Activation of the Hypoxia-Inducible Factor Reversibly Reduces Tendon Stem Cell Proliferation, Inhibits Their Differentiation, and Maintains Cell Undifferentiation
Alessandra Menon et al.
STEM CELLS INTERNATIONAL (2018)
Identification of a functional antioxidant response element at the HIF1A locus
Sarah E. Lacher et al.
REDOX BIOLOGY (2018)
Transcriptional Regulation by Nrf2
Claudia Tonelli et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Aldo Pezzuto et al.
CURRENT MOLECULAR MEDICINE (2018)
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
Karthik Kami Reddy et al.
ANGIOGENESIS (2018)
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
Nikki Buijs et al.
ANGIOGENESIS (2017)
Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
Rachel K. Toth et al.
ANTIOXIDANTS (2017)
Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2
Zukaa al Taleb et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
Noel A. Warfel et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells
Mingchuan Li et al.
ONCOLOGY REPORTS (2016)
Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms
Margaret M. Centenera et al.
ENDOCRINE-RELATED CANCER (2015)
Activation of Nuclear Factor Erythroid 2-Related Factor 2 Coordinates Dimethylarginine Dimethylaminohydrolase/PPAR-γ/Endothelial Nitric Oxide Synthase Pathways That Enhance Nitric Oxide Generation in Human Glomerular Endothelial Cells
Zaiming Luo et al.
HYPERTENSION (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools
Ren Dreos et al.
NUCLEIC ACIDS RESEARCH (2015)
Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants
Thomas L. Prince et al.
PLOS ONE (2015)
Hypoxia signaling pathways: modulators of oxygen-related organelles
Miriam J. Schonenberger et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Developing an Irreversible Inhibitor of Human DDAH-1, an Enzyme Upregulated in Melanoma
Yun Wang et al.
CHEMMEDCHEM (2014)
Transcriptional regulation by hypoxia inducible factors
Veronica L. Dengler et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α
Xiangjun Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect
Subrata Kumar Pore et al.
BIOMATERIALS (2013)
Angiogenesis and anti-angiogenic therapy in prostate cancer
Deborah Mukherji et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species
Rajitha T. Kolamunne et al.
REDOX BIOLOGY (2013)
Progress of molecular targeted therapies for prostate cancers
Weihua Fu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
iNOS-selective inhibitors for cancer prevention: promise and progress
Naveena B. Janakiram et al.
FUTURE MEDICINAL CHEMISTRY (2012)
NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α
Tae-Hyoung Kim et al.
CANCER RESEARCH (2011)
Oxygen Sensing, Homeostasis, and Disease
David De Bels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
Ramesh Ummanni et al.
PLOS ONE (2011)
MECHANISMS OF DISEASE Oxygen Sensing, Homeostasis, and Disease
Gregg L. Semenza
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory
Rong Hu et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction
Amaya Ortiz-Barahona et al.
NUCLEIC ACIDS RESEARCH (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer
Ramesh Ummanni et al.
CANCER LETTERS (2008)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein
Chang-Wu Lu et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2007)
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
AL Kung et al.
CANCER CELL (2004)
The role of hypoxia-induced factors in tumor progression
P Vaupel
ONCOLOGIST (2004)
Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression
D Vernimmen et al.
BIOCHEMICAL JOURNAL (2003)
Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
V Kostourou et al.
BRITISH JOURNAL OF CANCER (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
